Zydus Lifesciences jumps on reporting 53% rise in Q2 consolidated net profit

07 Nov 2023 Evaluate

Zydus Lifesciences is currently trading at Rs. 596.00, up by 11.65 points or 1.99% from its previous closing of Rs. 584.35 on the BSE.

The scrip opened at Rs. 584.40 and has touched a high and low of Rs. 602.50 and Rs. 584.40 respectively. So far 59499 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 668.50 on 10-Aug-2023 and a 52 week low of Rs. 390.10 on 22-Nov-2022.

Last one week high and low of the scrip stood at Rs. 602.50 and Rs. 570.35 respectively. The current market cap of the company is Rs. 60307.12 crore.

The promoters holding in the company stood at 74.98%, while Institutions and Non-Institutions held 17.95% and 7.07% respectively.

Zydus Lifesciences has reported results for second quarter ended September 30, 2023 (Q2FY24). The company has reported 78.45% rise in its net profit at Rs 805.00 crore for the quarter under review as compared to Rs 451.10 crore for the same quarter in the previous year. Total income of the company increased by 13.61% at Rs 2,693.80 crore for Q2FY24 as compared to Rs 2,371.00 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 53.24% rise in its net profit at Rs 800.70 crore for Q2FY24 as compared to Rs 522.50 crore for the same quarter in the previous year. Total income of the company increased by 9.21% at Rs 4,422.80 crore for Q2FY24 as compared to Rs 4,049.90 crore for the corresponding quarter previous year.


Zydus Lifesciences Share Price

876.10 3.15 (0.36%)
21-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.55
Dr. Reddys Lab 1155.50
Cipla 1369.55
Zydus Lifesciences 876.10
Lupin 2139.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×